- Home
- GHRS vs OLPX Comparison
GHRS vs OLPX Comparison
Compare GHRS & OLPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- OLPX
- Stock Information
- Founded
- GHRS 2018
- OLPX 2014
- Country
- GHRS Ireland
- OLPX United States
- Employees
- GHRS N/A
- OLPX N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- OLPX Package Goods/Cosmetics
- Sector
- GHRS Health Care
- OLPX Consumer Discretionary
- Exchange
- GHRS Nasdaq
- OLPX Nasdaq
- Market Cap
- GHRS 874.0M
- OLPX 1.0B
- IPO Year
- GHRS 2021
- OLPX 2021
- Fundamental
- Price
- GHRS $12.22
- OLPX $1.44
- Analyst Decision
- GHRS Strong Buy
- OLPX Buy
- Analyst Count
- GHRS 8
- OLPX 4
- Target Price
- GHRS $30.63
- OLPX $1.88
- AVG Volume (30 Days)
- GHRS 183.0K
- OLPX 1.0M
- Earning Date
- GHRS 08-07-2025
- OLPX 11-06-2025
- Dividend Yield
- GHRS N/A
- OLPX N/A
- EPS Growth
- GHRS N/A
- OLPX N/A
- EPS
- GHRS N/A
- OLPX N/A
- Revenue
- GHRS N/A
- OLPX $423,083,000.00
- Revenue This Year
- GHRS N/A
- OLPX $1.60
- Revenue Next Year
- GHRS N/A
- OLPX $3.09
- P/E Ratio
- GHRS N/A
- OLPX N/A
- Revenue Growth
- GHRS N/A
- OLPX N/A
- 52 Week Low
- GHRS $6.00
- OLPX $1.01
- 52 Week High
- GHRS $20.50
- OLPX $2.77
- Technical
- Relative Strength Index (RSI)
- GHRS 37.28
- OLPX 50.72
- Support Level
- GHRS $13.71
- OLPX $1.44
- Resistance Level
- GHRS $14.59
- OLPX $1.58
- Average True Range (ATR)
- GHRS 0.73
- OLPX 0.08
- MACD
- GHRS -0.09
- OLPX 0.00
- Stochastic Oscillator
- GHRS 4.62
- OLPX 19.31
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About OLPX Olaplex Holdings Inc.
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.